antigen presenting cells (APCs)
Showing 1 - 25 of >10,000
CD 19+ Acute Leukemia Trial in Seattle (T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC))
Active, not recruiting
- CD 19+ Acute Leukemia
- T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC)
-
Seattle, WashingtonSeattle Children's Hospital
Mar 22, 2022
Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)
Not yet recruiting
- Epithelial Ovarian Cancer
- Ovarian Carcinoma
- XP-DC vaccinations
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Center
Mar 6, 2023
Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)
Not yet recruiting
- Triple Negative Breast Cancer
- Cryoablation
- Cryoablation combined with PD1 Inhibitor
- (no location specified)
Mar 28, 2023
Autoimmune Hemolytic Anemia, Failure of Two Rounds of Treatment Trial in Zhoukou, Tianjin (Linperlisib)
Not yet recruiting
- Autoimmune Hemolytic Anemia
- Failure of Two Rounds of Treatment
-
Zhoukou, Henan, China
- +1 more
Jan 7, 2023
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Sipuleucel-T
-
Oklahoma City, OklahomaStephenson's Cancer Center
Mar 28, 2023
Advanced Solid Tumor Trial in Nijmegen (PRECIOUS-01)
Recruiting
- Advanced Solid Tumor
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Oct 26, 2022
Melanoma Trial in Germany (Lipo-MERIT)
Active, not recruiting
- Melanoma
- Lipo-MERIT
-
Frankfurt, Germany
- +3 more
Jan 5, 2023
HLA-DR in Cell Cultures Isolated From Primary Squamous Cell
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Cancer
- cell culture
-
Roma, Lazio, ItalyFondazione Policlinico Universitario Gemelli, Irccs
Sep 11, 2023
COVID-19 Trial in Rockville (Ad26 COVID-19 Spike plus TICE® BCG Mix for Intradermal Injection)
Active, not recruiting
- COVID-19
- Recombinant COVID-19 Spike Protein plus TICE® BCG Mix for percutaneous use
-
Rockville, Maryland
- +1 more
Jan 18, 2023
Dengue Trial in Lausanne (LD vehicle-GNP, LD PepGNP-Dengue, HD vehicle-GNP)
Completed
- Dengue
- LD vehicle-GNP
- +3 more
-
Lausanne, Vaud, SwitzerlandCenter for Primary Care and Public Health, (Unisante)
Nov 28, 2022
Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Lausanne (LD Vehicle-GNP, LD PepGNP-SARSCoV2, HD Vehicle-GNP)
Completed
- Coronavirus
- +2 more
- LD Vehicle-GNP
- +3 more
-
Lausanne, Vaud, SwitzerlandCenter for Primary Care and Public Health (Unisante)
Nov 28, 2022
Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- Testosterone Cypionate
- Sipuleucel-T
-
New Haven, ConnecticutYale Cancer Center
Oct 20, 2023
Environmental Enteric Dysfunction, Probiotic Trial in Guédiawaye (VSL#3, CapsCan, Placebo)
Not yet recruiting
- Environmental Enteric Dysfunction
- Probiotic
- VSL#3
- +2 more
-
Guédiawaye, Dakar, SenegalCentre de santé de Wakhinane
Aug 11, 2022
Cancer, Treatment-Related, Tumor of Breast, Systemic Inflammatory Response Trial in Roma (cryoablation)
Completed
- Cancer, Treatment-Related
- +3 more
- cryoablation
-
Roma, ItalySapienza University of Rome
Feb 13, 2023
Covid19 Trial in North Bethesda (COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection)
Active, not recruiting
- Covid19
- COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection
-
North Bethesda, MarylandMedicine Invention Design Incorporation (MIDI) - IORG0007849
Dec 2, 2021
Metastatic Androgen Independent Prostate Cancer Trial in Canada, United States (APC8015F)
Completed
- Metastatic Androgen Independent Prostate Cancer
- APC8015F
-
Los Angeles, California
- +57 more
Sep 3, 2021
Environmental Enteropathy Trial in Worldwide (dietary supplement, device, combination product)
Not yet recruiting
- Environmental Enteropathy
- VSL#3
- +2 more
-
Dhaka, Bangladesh
- +3 more
Nov 1, 2022
Primary ITP and Effect of Immunosuppressive Therapy on Its Level
Completed
- Idiopathic Thrombocytopenic Purpura
-
Assiut, EgyptMona
Jan 12, 2021
Covid19 Trial in Rockville (CoronaVac® plus TICE® BCG Mix for Intradermal Injection)
Active, not recruiting
- Covid19
- CoronaVac® plus TICE® BCG Mix for Intradermal Injection
-
Rockville, MarylandMIDI Clinical Trial Sites -c/o- Dr. Han Xu - Sponsor / Investiga
Jan 12, 2022
Advanced Liver Cancers Trial (DC-CIK)
Not yet recruiting
- Advanced Liver Cancers
- DC-CIK
- (no location specified)
Nov 11, 2022
Adenocarcinoma of the Prostate Trial in United States (sipuleucel-T)
Active, not recruiting
- Adenocarcinoma of the Prostate
- sipuleucel-T
-
Gilbert, Arizona
- +55 more
Jan 18, 2022
Pulmonary Osteosarcoma Trial (RNA-LP vaccine)
Not yet recruiting
- Pulmonary Osteosarcoma
- RNA-LP vaccine
- (no location specified)
Jan 25, 2023
Diffuse Intrinsic Pontine Glioma Trial in Beijing (Histone H3.3-K27M Neoantigen Vaccine Therapy)
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Histone H3.3-K27M Neoantigen Vaccine Therapy
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Jul 18, 2022
Sepsis, Acute Circulatory Failure Trial in Paris (Multiple blood sampling, Simple blood sampling)
Unknown status
- Sepsis
- Acute Circulatory Failure
- Multiple blood sampling
- Simple blood sampling
-
Paris, FranceCochin Hospital, AP-HP
Dec 2, 2019
Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Tumor Trial in Australia (Ipilimumab,
Recruiting
- Advanced Biliary Tract Cancer
- +3 more
-
Albury, New South Wales, Australia
- +11 more
Oct 31, 2022